We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

104 hedge funds and large institutions have $153M invested in Rigel Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 25

20% more call options, than puts

Call options by funds: $6K | Put options by funds: $5K

7% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 15

1% more funds holding

Funds holding: 103 → 104 (+1)

46% less capital invested

Capital invested by funds: $282M → $153M (-$129M)

Holders
104
Holders Change
+1
Holders Change %
+0.97%
% of All Funds
3.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
32
Reduced
25
Closed
15
Calls
$6K
Puts
$5K
Net Calls
+$1K
Net Calls Change
-$76K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$3.6M
2
SAM
Senzar Asset Management
New York
+$3.25M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.75M
4
BACM
Blue Arrow Capital Management
New York
+$1.69M
5
BC
Broadfin Capital
New York
+$1.13M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$3.7M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.44M
3
Norges Bank
Norges Bank
Norway
-$1.19M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.11M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$929K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
51
Nationwide Fund Advisors
Ohio
$298K – – –
WMSA
52
Weiss Multi-Strategy Advisers
New York
$291K – – –
MCM
53
Munder Capital Management
Michigan
$248K -$30.8K -1,091 -8%
USAA
54
United Services Automobile Association
Texas
$238K – – –
CS
55
Credit Suisse
Switzerland
$237K +$177K +6,282 +105%
TA
56
Teachers Advisors
New York
$233K – – –
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$223K – – –
PRC
58
Platte River Capital
Colorado
$190K +$277K +9,790 New
Goldman Sachs
59
Goldman Sachs
New York
$187K -$196K -6,924 -42%
VOYA Investment Management
60
VOYA Investment Management
Georgia
$183K – – –
Swiss National Bank
61
Swiss National Bank
Switzerland
$178K – – –
State Board of Administration of Florida Retirement System
62
State Board of Administration of Florida Retirement System
Florida
$159K – – –
ProShare Advisors
63
ProShare Advisors
Maryland
$154K -$44.3K -1,567 -16%
Bank of America
64
Bank of America
North Carolina
$124K +$79.7K +2,823 +79%
Invesco
65
Invesco
Georgia
$116K +$9.07K +321 +6%
California Public Employees Retirement System
66
California Public Employees Retirement System
California
$111K – – –
AIG
67
American International Group
New York
$111K -$113 -4 -0.1%
DekaBank Deutsche Girozentrale
68
DekaBank Deutsche Girozentrale
Germany
$100K +$2.83K +100 +2%
Jane Street
69
Jane Street
New York
$91K +$133K +4,713 New
PP
70
Paloma Partners
Connecticut
$88K +$128K +4,548 New
PPA
71
Parametric Portfolio Associates
Washington
$87K -$76.4K -2,705 -38%
Public Employees Retirement Association of Colorado
72
Public Employees Retirement Association of Colorado
Colorado
$74K – – –
Allianz Asset Management
73
Allianz Asset Management
Germany
$68K – – –
SG Americas Securities
74
SG Americas Securities
New York
$68K +$99.5K +3,522 New
Susquehanna International Group
75
Susquehanna International Group
Pennsylvania
$62K -$53.6K -1,897 -37%
1 2
3
4 5

RIGL Hedge Fund Activity: Q3 2014 in Review

104 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q3 2014, worth a combined $153M — down 46% from $282M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new RIGL positions and 15 closed out — a net gain of 1 holder — while 32 added to existing stakes and 25 trimmed.

The largest buyer was Millennium Management, adding an estimated $3.6M. The largest seller was Morgan Stanley, cutting an estimated $3.7M.

  • 104 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q3 2014, up from 103 in Q2 2014.
  • Funds reported $153M of Rigel Pharmaceuticals stock for Q3 2014, down 46% quarter-over-quarter.
  • 16 funds opened new Rigel Pharmaceuticals positions in Q3 2014 and 15 closed out, a net change of +1 holder.
  • The largest Rigel Pharmaceuticals buyer in Q3 2014 was Millennium Management, an estimated $3.6M added.
  • The largest Rigel Pharmaceuticals seller in Q3 2014 was Morgan Stanley, an estimated $3.7M sold.

Based on aggregated 13F filings for Q3 2014.